The FDA awarded Apollo Endosurgery’s OverStitch Sx system FDA 510(k) clearance.
The FDA granted Ferring Pharmaceuticals approval to market Clenpiq, an oral solution for colon preparation.
CSA Medical announced the enrollment of the first patient into a multicenter study evaluating its spray cryotherapy on esophageal cancer patients. The patient was treated at Chapel Hill-based University of North Carolina’s Center for Esophageal Diseases and Swallowing.
More articles on gastroenterology:
9 GI leaders to know for November
Stock market week-in-review for 5 large GI companies — Nov. 20-24
6 insights into Crohn’s on a global level — US has 993k cases
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.